IDT Australia Limited announced the appointment of Dr. David Sparling as interim Chief Executive Officer, effective immediately. Dr. Sparling is currently Vice President of Corporate & Business Development at IDT and brings a wealth of experience in the pharmaceutical industry to the role. With the recent senior appointments of Mr. Jim Sosic as Vice President of Operations, along with Mr. Gordon Brien as Vice President of Quality the company's strengthened leadership team's primary focus is on execution to the operational plan.

Mr. Graeme Kaufman and Ms. Mary Sontrop will cease their executive roles with immediate effect, remaining as nonexecutive directors.